Physician
Internal Medicine
Dr. George C. Wagner, MD
|
|
Give Review
Doctor George C. Wagner, MD works in the field of Internal Medicine. George C. Wagner, MD is a published doctor and has 100 publications published. The lastest was: 'Methamphetamine-induced changes in activity and water intake during light and dark cycles in rats.'
Publications
- Ephrin-A5 regulates inter-male aggression in mice.
- Altered behavioral development in Nrf2 knockout mice following early postnatal exposure to valproic acid.
- Gastrointestinal Dysfunction in Children With Autism Spectrum Disorders.
- Abstracts of Presentations at the International Conference on Basic and Clinical Multimodal Imaging (BaCI), a Joint Conference of the International Society for Neuroim...
- Oral Caffeine During Voluntary Exercise Markedly Inhibits Skin Carcinogenesis and Decreases Inflammatory Cytokines in UVB-Treated Mice.
- Ephrin-A5 deficiency alters sensorimotor and monoaminergic development.
- Inhibition of UVB-induced nonmelanoma skin cancer: a path from tea to caffeine to exercise to decreased tissue fat.
- Effects of high fat diets rich in either omega-3 or omega-6 fatty acids on UVB-induced skin carcinogenesis in SKH-1 mice.
- Inhibitory effect of dietary atorvastatin and celecoxib together with voluntary running wheel exercise on the progression of androgen-dependent LNCaP prostate tumors t...
- Dopamine-induced behavioral changes and oxidative stress in methamphetamine-induced neurotoxicity.
- Targeted disruption of the Pak5 and Pak6 genes in mice leads to deficits in learning and locomotion.
- Voluntary exercise together with oral caffeine markedly stimulates UVB light-induced apoptosis and decreases tissue fat in SKH-1 mice.
- Stimulatory effect of voluntary exercise or fat removal (partial lipectomy) on apoptosis in the skin of UVB light-irradiated mice.
- A new neurobehavioral model of autism in mice: pre- and postnatal exposure to sodium valproate.
- Liver fat and plasma ethanol are sharply lower in rats fed ethanol in conjunction with high carbohydrate compared with high fat diets.
- Functional deficits in pak5, pak6 and pak5/pak6 knockout mice.
- The effects of prenatal morphine on the responsiveness to morphine and amphetamine.
- L-dopa reverses the effects of MPP+ toxicity.
- Increased sensitivity of mice to tremorogenic agents following MPP+.
- Inhibitory effects of ginseng total saponin on methamphetamine-induced striatal dopamine increase in mice.
- Effect of concomitant ingestion of alcohol on the in vivo pharmacokinetics of KADIAN (morphine sulfate extended-release) capsules.
- Effects of methamphetamine on atropine-induced conditioned gustatory avoidance.
- The effects of dopaminergic agents on the locomotor activity of rats after high doses of methylamphetamine.
- Interactions of naloxone and haloperidol with phencyclidine: effects on milk intake.
- Effects of a high-dose treatment of methamphetamine on caudate dopamine and anorexia in rats.
- Neurochemical similarities between d,l-cathinone and d-amphetamine.
- Tolerance following the repeated administration of high doses of phencyclidine: no relation to central catecholamine depletion.
- Effects of phencyclidine, haloperidol, and naloxone on fixed-interval performance in rats.
- Effect of gestational and lactational 2,3,7, 8-tetrachlorodibenzo-p-dioxin exposure on the level and catalytic activities of hepatic microsomal CYP1A in prepubertal an...
- Cocaine blocks the dopamine depletion induced by MPTP.
- Ginseng total saponin inhibits the dopaminergic depletions induced by methamphetamine.
- Acute and chronic effects of ginseng total saponin and amphetamine on fixed-interval performance of rats.
- Pargyline and naltrexone fail to antagonize the gustatory avoidance response induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
- Dopamine depletion by 6-hydroxydopamine prevents conditioned taste aversion induced by methylamphetamine but not lithium chloride.
- Methamphetamine-induced changes in brain catecholamines in rats and guinea pigs.
- Long-term effects of repeated methylamphetamine administration on monoamine neurons in the rhesus monkey brain.
- Neurochemical consequences following administration of CNS stimulants to the neonatal rat.
- Acute effects of aspartame on aggression and neurochemistry of rats.
- Decreased sensitivity of rat pups to long-lasting dopamine and serotonin depletions produced by methylamphetamine.
- Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats.
- Changes in macronutrient selection as a function of dietary tryptophan.
- Attenuation of MPTP-induced dopaminergic neurotoxicity by a serotonin uptake blocker.
- Effects of fluprazine (DU27716) and ethanol on target biting behavior and intruder-evoked attacks.
- Astrocytes as a primary locus for the conversion MPTP into MPP+.
- The effects of repeated administration of fluprazine on target biting and intruder-evoked attacks.
- Ascorbic acid reduces the dopamine depletion induced by MPTP.
- Sexual differences in sensitivity to methamphetamine toxicity.
- Functional consequences following methamphetamine-induced neuronal damage.
- Acute and chronic effects of ginseng total saponin and amphetamine on fixed-interval performance in rats.
- Suppression of ethanol intake in chickens by fenfluramine and dietary tryptophan.
- Monoaminergic changes associated with audiogenic seizures in ethanol-dependent rats.
- Novel synergistic treatment of ethanol withdrawal seizures in rats with dopamine and serotonin agonists.
- Ethanol consumption following acute fenfluramine, fluoxetine, and dietary tryptophan.
- Ethanol intake of chickens treated with fenfluramine, fluoxetine, and dietary tryptophan.
- Ethanol consumption following acute treatment with methysergide, fluoxetine, fenfluramine, and their combination.
- Cocaine-induced expression of the tetraspanin CD81 and its relation to hypothalamic function.
- L-DOPA exacerbates amphetamine-induced dopamine depletion.
- Alpha-methyltyrosine attenuates and reserpine increases methamphetamine-induced neuronal changes.
- Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine.
- Ascorbic acid reduces the dopamine depletion induced by methamphetamine and the 1-methyl-4-phenyl pyridinium ion.
- Evaluation of the pharmacological similarities between phenylpropanolamine and amphetamine: effects on schedule-controlled behavior.
- Propranolol-induced increases in target-biting attack.
- Evaluation of the effects of inhibition of monoamine oxidase and senescence on methamphetamine-induced neuronal damage.
- Methamphetamine-induced neuronal damage: a possible role for free radicals.
- Age-dependent effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP).
- Motor impairments after methamphetamine-induced neurotoxicity in the rat.
- Age-dependent effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): correlation with monoamine oxidase-B.
- Fenfluramine-induced behavior changes in rats prefed serotonin-altering amounts of tryptophan and pyridoxine.
- Alcohol utilization and dependence with special reference to protein level in a liquid diet for rats.
- Alterations in alcohol consumption, withdrawal seizures, and monoamine transmission in rats treated with phentermine and 5-hydroxy-L-tryptophan.
- Uridine and stimulant-induced motor activity.
- Efficacy of providing nicotine in a liquid diet to rats.
- Dietary pyridoxine interaction with tryptophan or histidine on brain serotonin and histamine metabolism.
- 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the rat: characterization and age-dependent effects.
- Influence of gonadal hormones on sexual differences in sensitivity to methamphetamine-induced neurotoxicity.
- Diet composition, alcohol utilization, and dependence.
- Regulation of EphB1 expression by dopamine signaling.
- Simultaneous changes in striatal dopamine, serotonin, and metabolites after withdrawal seizures in rats from dependence on alcohol.
- Effects of monoaminergic agonists on alcohol-induced increases in mouse aggression.
- Neurotoxic effects of amphetamine plus L-DOPA.
- Effects of phentermine and fenfluramine on alcohol consumption and alcohol withdrawal seizures in rats.
- Differential effects of monoaminergic agonists on alcohol intake in rats fed a tryptophan-enhanced diet.
- Neurochemical and functional consequences following 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) and methamphetamine.
- Specification of distinct dopaminergic neural pathways: roles of the Eph family receptor EphB1 and ligand ephrin-B2.
- Neurochemical and motor effects of high dose haloperidol treatment: exacerbation by tryptophan supplementation.
- Increased excretion of a lipid peroxidation biomarker in autism.
- Dose-dependent up-regulation of rat pulmonary, renal, and hepatic cytochrome P-450 (CYP) 1A expression by nicotine feeding.
- Methamphetamine-induced striatal dopamine release, behavior changes and neurotoxicity in BALB/c mice.
- Amphetamine and fenfluramine suppress ethanol intake in ethanol-dependent rats.
- Altered sensitivity of CD81-deficient mice to neurobehavioral effects of cocaine.
- The effects of deprenyl on methamphetamine-induced dopamine depletions.
- Uridine potentiates haloperidol''s disruption of conditioned avoidance responding.
- Evaluation of the effects of alpha-phenyl-N-tert-butyl nitrone pretreatment on the neurobehavioral effects of methamphetamine.
- Partial 6-hydroxydopamine-induced lesions and haloperidol-induced catalepsy.
- The effects of L-tryptophan on haloperidol-induced movement disorder in the rat.
- Hydroxyl radical formation following methamphetamine administration to rats.
- Effects of pargyline and pyrogallol on the methamphetamine-induced dopamine depletion.
- Interaction of phentermine plus fenfluramine: neurochemical and neurotoxic effects.
- Methamphetamine-induced changes in activity and water intake during light and dark cycles in rats.
Schools
University of Miami School of Medicine
Grady Mem Hospital
Doctors Specialties
- Internal Medicine
Accepted Insurances
Drug Facts
| NPI NUMBER | 1275504078 | |
| NPPES Provider LastName | WAGNER | |
| NPPES Provider FirstName | GEORGE | |
| NPPES Provider ZIPCode | 240185024 | |
| NPPES Provider State | VA | |
| Specialty Description | General Practice | |
| Total Claim Count | 2272.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 96.0 | |
| Percent Opioid Claims | 4.23 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1275504078 |
| Last Name Of The Provider | WAGNER |
| First Name Of The Provider | GEORGE |
| View All |
Similar Doctors
|
|
Dr. Megan C. Thomas, DO
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Thomas S. Jamison, MD |
|
|
Dr. Arif A. Khan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael E. Slayton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allison B. Greenstein, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ambihai K. Sinnadurai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael K. Conatser, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erin C. Carter, DO |
|
|
Dr. Najib Sawaya, MD
This Doctor is OpenDoctor Recommended.
|